The Board of Aspen Pharmacare Holdings Limited announced that it has appointed Mr. Ben Kruger to succeed Mr. Roy Andersen as the Lead Independent Non-executive Director with effect from 1 October 2019. As announced on 7 March 2019, Mr. Andersen will retire from the Board with effect from 30 September 2019. The Board extends its sincere appreciation to Mr. Andersen for his dedicated service to Aspen as Lead Independent Director, chairman of its Remuneration & Nomination Committee and member of its Audit & Risk Committee, roles he has performed with diligence and distinction since 2008.